Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKesson
Colorcon
Merck
Johnson and Johnson

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

ASPIRIN; MEPROBAMATE - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for ASPIRIN; MEPROBAMATE
US Patents:0
Tradenames:5
Applicants:5
NDAs:5
Drug Master File Entries: 22
DailyMed Link:ASPIRIN; MEPROBAMATE at DailyMed

US Patents and Regulatory Information for ASPIRIN; MEPROBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc MICRAININ aspirin; meprobamate TABLET;ORAL 084978-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm MEPROBAMATE AND ASPIRIN aspirin; meprobamate TABLET;ORAL 089126-001 Aug 19, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz MEPRO-ASPIRIN aspirin; meprobamate TABLET;ORAL 089127-001 Mar 2, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries EQUAGESIC aspirin; meprobamate TABLET;ORAL 011702-003 Dec 29, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Quantum Pharmics Q-GESIC aspirin; meprobamate TABLET;ORAL 088740-001 Jun 1, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Mallinckrodt
McKesson
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.